Ensysce Biosciences (ENSC) Cash & Current Investments (2017 - 2025)
Ensysce Biosciences (ENSC) posted Cash & Current Investments of $4.31 million for Q4 2025, up 23.1% from $3.5 million a year earlier and up 157.6% from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Cash & Current Investments (2017 - 2025) Analysis & Trends
Since Q4 2017, Ensysce Biosciences has reported Cash & Current Investments for 33 quarters.
- Annual Cash & Current Investments shows a five-year compound annual growth rate of 85.9% (FY2020 to FY2025).
- In prior years, Ensysce Biosciences' Cash & Current Investments was $3.5 million in FY2024 (+211.7%), $1.12 million in FY2023 (-64.3%), $3.15 million in FY2022 (-74.3%) and $12.26 million in FY2021.
- The Q4 2025 figure stands as the highest quarterly Cash & Current Investments since Q3 2022.
- On a year-over-year basis, Cash & Current Investments increased in five of the last eight quarters, with growth averaging 66.0%.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q4 2024, with growth of 211.7%; the weakest was Q1 2021, with a decline of 89.3%.
- According to Business Quant data, Cash & Current Investments for the three prior quarters was $1.67 million (Q3 2025), $2.21 million (Q2 2025) and $3.05 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Ensysce Biosciences | 1.20 Mn | -10.05 Mn | - | 4.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 4.31 Mn |
| Sep 30, 2025 | 1.67 Mn |
| Jun 30, 2025 | 2.21 Mn |
| Mar 31, 2025 | 3.05 Mn |
| Dec 31, 2024 | 3.50 Mn |
| Sep 30, 2024 | 4.15 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 3.40 Mn |
| Dec 31, 2023 | 1.12 Mn |
| Sep 30, 2023 | 1.46 Mn |
| Jun 30, 2023 | 3.83 Mn |
| Mar 31, 2023 | 1.42 Mn |
| Dec 31, 2022 | 3.15 Mn |
| Sep 30, 2022 | 4.50 Mn |
| Jun 30, 2022 | 3.73 Mn |
| Mar 31, 2022 | 8.44 Mn |
| Dec 31, 2021 | 12.26 Mn |
| Sep 30, 2021 | 6.85 Mn |
| Jun 30, 2021 | 8.01 Mn |
| Mar 31, 2021 | 18,034.00 |
API Access
Ensysce Biosciences Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();